Latest news
How (RCKT) Movements Inform Risk Allocation Models - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 11:40:01 GMTRocket Pharmaceuticals, Inc. (RCKT) Class Action Lawsuit: Levi - The National Law ReviewThe National Law Review · Fri, 07 Aug 2026 05:12:39 GMTRocket Pharmaceuticals, Inc. Revenue Breakdown – BOATS:RCKTW - TradingViewTradingView · Thu, 06 Aug 2026 19:20:22 GMTRocket Pharmaceuticals Inc (RCKT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Thu, 06 Aug 2026 07:00:00 GMTMorgan Stanley Maintains Rocket Pharmaceuticals(RCKT.US) With Hold Rating, Maintains Target Price $5 - MoomooMoomoo · Tue, 04 Aug 2026 15:33:00 GMTRocket Pharmaceuticals Touts Positive Early Safety Data from Revised Genetic Therapy Trial - BenzingaBenzinga · Mon, 03 Aug 2026 16:03:07 GMTRocket Pharmaceuticals (RCKT) Reports Positive Safety Signals in Phase 2 Trial for Danon Disease - GuruFocusGuruFocus · Mon, 03 Aug 2026 13:01:56 GMTRocket Pharmaceuticals Inc expected to post earnings of 37 cents a share - Earnings Preview - TradingViewTradingView · Mon, 03 Aug 2026 11:25:16 GMT